Corcept Therapeutics Incorporated (United States) is listed on the Nasdaq and has a market capitalization of $7.67 billion, with shareholders equity totaling $833.74 million.
The company employs approximately 206 people and operates in the Health sector, within the Pharmaceutical Products industry.
Over the past 12 months, Corcept Therapeutics Incorporated reported $963.65 million in revenue, generating net income of $162.29 million.
Key financial metrics include a P/E ratio of 47.24, a price-to-book (P/B) ratio of 9.20, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker CORT.